Literature DB >> 6275872

Antagonism of pancuronium in renal failure: no recurarization.

D R Bevan, D Archer, F Donati, A Ferguson, B D Higgs.   

Abstract

Neuromuscular transmission was measured using train-of-four stimulation, during and after anaesthesia, in 20 patients with end-stage renal failure. Neuromuscular blockade was provided with pancuronium in single doses of either 3 or 6 mg per 70 kg, and antagonized at 10% recovery with atropine and neostigmine 2.5 mg per 70 kg. Reversal was followed by progressive recovery of muscle twitch in every patient during the 3 h of the study. Recovery was more rapid after the smaller dose of pancuronium and was inversely correlated with the duration of blockade. It is concluded that, when pancuronium is antagonized with neostigmine in patients with renal failure, neuromuscular transmission recovers without evidence of recurarization. However, when large doses of pancuronium are antagonized with neostigmine 2.5 mg, recovery may be insufficient to ensure normal ventilatory function.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6275872     DOI: 10.1093/bja/54.1.63

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  Neuromuscular blocking drugs in anaesthesia.

Authors:  F Donati; J C Bevan; D R Bevan
Journal:  Can Anaesth Soc J       Date:  1984-05

2.  Vecuronium in renal failure.

Authors:  D R Bevan; F Donati; H Gyasi; A Williams
Journal:  Can Anaesth Soc J       Date:  1984-09

3.  Virus-like particle capsid proteins encoded by different L double-stranded RNAs of Saccharomyces cerevisiae: their roles in maintenance of M double-stranded killer plasmids.

Authors:  M El-Sherbeini; D J Tipper; D J Mitchell; K A Bostian
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.